# Clinical Trial of YYD302 (Phase3) for Treatment of Osteoarthritis of the Knee

> **NCT03561779** · PHASE3 · COMPLETED · sponsor: **Yooyoung Pharmaceutical Co., Ltd.** · enrollment: 184 (actual)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **DRUG:** YYD302 2ml
- **DRUG:** Active comparator: Synovian Inj.

## Key facts

- **NCT ID:** NCT03561779
- **Lead sponsor:** Yooyoung Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-21
- **Primary completion:** 2019-06-14
- **Final completion:** 2019-10-04
- **Target enrollment:** 184 (ACTUAL)
- **Last updated:** 2021-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03561779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03561779, "Clinical Trial of YYD302 (Phase3) for Treatment of Osteoarthritis of the Knee". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03561779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*